Katja A. Puttonen

1.5k total citations
29 papers, 1.1k citations indexed

About

Katja A. Puttonen is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Katja A. Puttonen has authored 29 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 9 papers in Oncology. Recurrent topics in Katja A. Puttonen's work include Pluripotent Stem Cells Research (8 papers), Cell death mechanisms and regulation (5 papers) and Peptidase Inhibition and Analysis (4 papers). Katja A. Puttonen is often cited by papers focused on Pluripotent Stem Cells Research (8 papers), Cell death mechanisms and regulation (5 papers) and Peptidase Inhibition and Analysis (4 papers). Katja A. Puttonen collaborates with scholars based in Finland, Sweden and United States. Katja A. Puttonen's co-authors include Jari Koıstınaho, Šárka Lehtonen, Minna Oksanen, Pasi Tavi, Nikolay Naumenko, Pekka T. Männistö, Atso Raasmaja, Marika Ruponen, Riikka H. Hämäläinen and Anastasia Shakirzyanova and has published in prestigious journals such as Scientific Reports, Free Radical Biology and Medicine and Frontiers in Immunology.

In The Last Decade

Katja A. Puttonen

29 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katja A. Puttonen Finland 18 568 334 231 225 142 29 1.1k
Iolanda D’Alimonte Italy 23 549 1.0× 446 1.3× 325 1.4× 142 0.6× 85 0.6× 31 1.4k
Yolanda de Pablo Sweden 19 584 1.0× 298 0.9× 327 1.4× 199 0.9× 63 0.4× 26 1.2k
Dongsheng Wu United Kingdom 20 519 0.9× 425 1.3× 160 0.7× 117 0.5× 57 0.4× 32 1.3k
Lidia De Filippis Italy 22 849 1.5× 411 1.2× 162 0.7× 171 0.8× 101 0.7× 43 1.6k
Galina Erikson United States 15 759 1.3× 220 0.7× 372 1.6× 234 1.0× 66 0.5× 23 1.4k
Era Taoufik Greece 15 399 0.7× 242 0.7× 202 0.9× 105 0.5× 143 1.0× 24 953
Roeben N. Munji United States 9 633 1.1× 282 0.8× 634 2.7× 136 0.6× 125 0.9× 11 1.5k
Anthony O. Caggiano United States 20 375 0.7× 395 1.2× 258 1.1× 120 0.5× 61 0.4× 39 1.2k
Miriam E. van Strien Netherlands 23 593 1.0× 278 0.8× 383 1.7× 166 0.7× 127 0.9× 32 1.5k
John N. Mariani United States 13 508 0.9× 286 0.9× 569 2.5× 167 0.7× 154 1.1× 21 1.3k

Countries citing papers authored by Katja A. Puttonen

Since Specialization
Citations

This map shows the geographic impact of Katja A. Puttonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katja A. Puttonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katja A. Puttonen more than expected).

Fields of papers citing papers by Katja A. Puttonen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katja A. Puttonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katja A. Puttonen. The network helps show where Katja A. Puttonen may publish in the future.

Co-authorship network of co-authors of Katja A. Puttonen

This figure shows the co-authorship network connecting the top 25 collaborators of Katja A. Puttonen. A scholar is included among the top collaborators of Katja A. Puttonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katja A. Puttonen. Katja A. Puttonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zitta, Karina, Rouven Berndt, Katharina Heß, et al.. (2025). Transcriptomic characterization of GMP-compliant regulatory macrophages (TRI-001) under inflammatory and hypoxic conditions: a comparative analysis across macrophage subtypes. Journal of Translational Medicine. 23(1). 551–551. 1 indexed citations
2.
Puttonen, Katja A., et al.. (2023). Cytokines impact natural killer cell phenotype and functionality against glioblastoma in vitro. Frontiers in Immunology. 14. 1227064–1227064. 9 indexed citations
3.
Sonninen, Tuuli-Maria, Riikka H. Hämäläinen, Marja Koskuvi, et al.. (2020). Metabolic alterations in Parkinson’s disease astrocytes. Scientific Reports. 10(1). 14474–14474. 123 indexed citations
4.
Gurvich, Olga L., Katja A. Puttonen, Aubrey Bailey, et al.. (2020). Transcriptomics uncovers substantial variability associated with alterations in manufacturing processes of macrophage cell therapy products. Scientific Reports. 10(1). 14049–14049. 23 indexed citations
5.
Puttonen, Katja A., et al.. (2020). Translation of small-scale CAR-T cell manufacturing methods to a clinical-scale production platform. Cytotherapy. 22(5). S127–S128. 1 indexed citations
6.
Tiihonen, Jari, Marja Koskuvi, Markku Lähteenvuo, et al.. (2019). Neurobiological roots of psychopathy. Molecular Psychiatry. 25(12). 3432–3441. 23 indexed citations
7.
Koponen, Jonna K., Tuija Kekarainen, Katja A. Puttonen, et al.. (2018). Temporal Dynamics of Gene Expression During Endothelial Cell Differentiation From Human iPS Cells: A Comparison Study of Signalling Factors and Small Molecules. Frontiers in Cardiovascular Medicine. 5. 16–16. 10 indexed citations
8.
Pinto, Sara, Carolina Cunha, Ana Rita Vaz, et al.. (2018). Human iPSC-derived neurons and astrocytes as models of neurodegeneration, neuroinflammation and vesicular trafficking in Alzheimer's disease. Free Radical Biology and Medicine. 120. S158–S158. 2 indexed citations
9.
Oksanen, Minna, Katja A. Puttonen, Riikka H. Hämäläinen, et al.. (2018). Generation of a human induced pluripotent stem cell line (LL008 1.4) from a familial Alzheimer's disease patient carrying a double KM670/671NL (Swedish) mutation in APP gene. Stem Cell Research. 31. 181–185. 8 indexed citations
10.
Oksanen, Minna, Andrew J. Petersen, Nikolay Naumenko, et al.. (2017). PSEN1 Mutant iPSC-Derived Model Reveals Severe Astrocyte Pathology in Alzheimer's Disease. Stem Cell Reports. 9(6). 1885–1897. 235 indexed citations
11.
Hujala, Anneli, et al.. (2015). Dancing with the Bosses: Creative Movement as a Method. Digital WPI. 15 indexed citations
12.
Korhonen, Paula, Katja M. Kanninen, Šárka Lehtonen, et al.. (2015). Immunomodulation by interleukin-33 is protective in stroke through modulation of inflammation. Brain Behavior and Immunity. 49. 322–336. 118 indexed citations
13.
Puttonen, Katja A., et al.. (2013). Improved Method of Producing Human Neural Progenitor Cells of High Purity and in Large Quantities from Pluripotent Stem Cells for Transplantation Studies. Cell Transplantation. 22(10). 1753–1766. 10 indexed citations
14.
Ossola, Bernardino, et al.. (2011). Minocycline protects SH‐SY5Y cells from 6‐hydroxydopamine by inhibiting both caspase‐dependent and ‐independent programmed cell death. Journal of Neuroscience Research. 90(3). 682–690. 21 indexed citations
15.
Puttonen, Katja A., Jofre Tenorio‐Laranga, Jarkko I. Venäläinen, et al.. (2011). Prolyl Endopeptidase Is Involved in Cellular Signalling in Human Neuroblastoma SH-SY5Y Cells. Neurosignals. 19(2). 97–109. 24 indexed citations
16.
Jalkanen, Aaro J., et al.. (2009). Different Effects of Scopolamine and Inhibition of Prolyl Oligopeptidase on Mnemonic and Motility Functions of Young and 8‐ to 9‐Month‐Old Rats in the Radial‐Arm Maze. Basic & Clinical Pharmacology & Toxicology. 106(4). 280–287. 14 indexed citations
17.
Puttonen, Katja A., Šárka Lehtonen, Pasi Lampela, Pekka T. Männistö, & Atso Raasmaja. (2007). Different viabilities and toxicity types after 6-OHDA and Ara-C exposure evaluated by four assays in five cell lines. Toxicology in Vitro. 22(1). 182–189. 24 indexed citations
18.
Puttonen, Katja A., Šárka Lehtonen, Atso Raasmaja, & Pekka T. Männistö. (2006). A prolyl oligopeptidase inhibitor, Z-Pro-Prolinal, inhibits glyceraldehyde-3-phosphate dehydrogenase translocation and production of reactive oxygen species in CV1-P cells exposed to 6-hydroxydopamine. Toxicology in Vitro. 20(8). 1446–1454. 32 indexed citations
19.
Jalkanen, Aaro J., Katja A. Puttonen, Jarkko I. Venäläinen, et al.. (2006). Beneficial Effect of Prolyl Oligopeptidase Inhibition on Spatial Memory in Young but Not in Old Scopolamine‐Treated Rats. Basic & Clinical Pharmacology & Toxicology. 100(2). 132–138. 41 indexed citations
20.
Puttonen, Katja A., et al.. (2003). Increased p53 levels without caspase-3 activity and change of cell viability in 6-hydroxydopamine-treated CV1-P cells. Cell Biology and Toxicology. 19(3). 177–187. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026